We provide you with 20 years of free, institutional-grade data for COLL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of COLL. Explore the full financial landscape of COLL stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$3,030,537
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Smith Thomas B | Sale | -17,478 | $38.42 | $671,576 | 2025-09-03 |
| Dreyer Scott | Sale | -16,389 | $38.21 | $626,171 | 2025-08-20 |
| Dreyer Scott | Derivatives Exercise | 16,389 | 2025-08-20 | ||
| SANTINI GINO | Sale | -5,405 | $37.19 | $201,018 | 2025-08-19 |
| SANTINI GINO | Derivatives Exercise | 15,000 | 2025-08-19 | ||
| Dreyer Scott | Sale | -4,861 | $38.03 | $184,881 | 2025-08-15 |
| Dreyer Scott | Derivatives Exercise | 4,861 | 2025-08-15 | ||
| Rubric Capital Management LP | Sale | -25,000 | $37.85 | $946,250 | 2025-08-15 |
| Freund John Gordon | Sale | -11,659 | $34.36 | $400,641 | 2025-08-12 |
| Freund John Gordon | Sale | -6,601 | $30.62 | $202,149 | 2025-06-11 |
| Freund John Gordon | Derivatives Exercise | 15,000 | 2025-06-11 | ||
| Freund John Gordon | Grant, award...etc | 9,791 | 2025-05-19 | ||
| Paya Carlos V | Grant, award...etc | 19,582 | 2025-05-19 | ||
| SANTINI GINO | Grant, award...etc | 9,791 | 2025-05-19 | ||
| Fallon John A. | Grant, award...etc | 9,791 | 2025-05-19 | ||
| BOHLIN GAREN G | Grant, award...etc | 9,791 | 2025-05-19 | ||
| Balice-Gordon Rita J. | Grant, award...etc | 9,791 | 2025-05-19 | ||
| Lurker Nancy | Grant, award...etc | 9,791 | 2025-05-19 | ||
| Tupper Colleen | Sale | -7,602 | $30 | $228,068 | 2025-03-24 |
| Dreyer Scott | Sale | -20,808 | $30 | $624,250 | 2025-03-24 |
| Dieter David | Grant, award...etc | 68,449 | 2025-03-19 | ||
| Tupper Colleen | Sale | -977 | $30 | $29,313 | 2025-03-18 |
| Dreyer Scott | Sale | -17,642 | $30 | $529,346 | 2025-03-18 |
| Dreyer Scott | Sale | -15,387 | $30 | $461,672 | 2025-03-13 |
| Tupper Colleen | Sale | -10,445 | $30.01 | $313,413 | 2025-03-13 |
| Dreyer Scott | Sale | -5,643 | $30 | $169,296 | 2025-03-10 |
| Tupper Colleen | Sale | -3,453 | $30 | $103,590 | 2025-03-10 |
| Kuhlmann Shirley R. | Sale | -86,067 | $28.08 | $2,416,675 | 2025-03-06 |
| Kuhlmann Shirley R. | Derivatives Exercise | 40,000 | 2025-03-06 | ||
| Kuhlmann Shirley R. | Sale | -34,975 | $30.52 | $1,067,437 | 2025-02-12 |
| Kuhlmann Shirley R. | Grant, award...etc | 69,995 | 2025-02-12 | ||
| Dreyer Scott | Sale | -29,623 | $30.52 | $904,094 | 2025-02-12 |
| Dreyer Scott | Grant, award...etc | 71,427 | 2025-02-12 | ||
| Smith Thomas B | Sale | -5,897 | $30.52 | $179,976 | 2025-02-12 |
| Smith Thomas B | Grant, award...etc | 39,075 | 2025-02-12 | ||
| Tupper Colleen | Sale | -30,426 | $30.52 | $928,602 | 2025-02-12 |
| Tupper Colleen | Grant, award...etc | 78,725 | 2025-02-12 | ||
| Heffernan Michael Thomas | Grant, award...etc | 4,820 | 2025-02-12 | ||
| Lurker Nancy | Grant, award...etc | 12,726 | 2025-02-05 | ||
| Kuhlmann Shirley R. | Sale | -27,500 | $32.87 | $903,911 | 2025-01-14 |
| Kuhlmann Shirley R. | Derivatives Exercise | 27,500 | 2025-01-14 | ||
| Karnani Vikram | Grant, award...etc | 105,972 | 2024-11-14 | ||
| Smith Thomas B | Sale | -9,593 | $36.62 | $351,320 | 2024-09-17 |
| Kuhlmann Shirley R. | Sale | -20,225 | $38.18 | $772,191 | 2024-09-06 |
| Kuhlmann Shirley R. | Sale | -25,000 | $32.55 | $813,710 | 2024-06-05 |
| Tupper Colleen | Sale | -19,710 | $34.21 | $674,368 | 2024-05-29 |
| Dreyer Scott | Sale | -108,016 | $33.82 | $3,653,533 | 2024-05-28 |
| Dreyer Scott | Derivatives Exercise | 75,000 | 2024-05-28 | ||
| Fallon John A. | Grant, award...etc | 7,693 | 2024-05-16 | ||
| Balice-Gordon Rita J. | Grant, award...etc | 7,693 | 2024-05-16 | ||
| BOHLIN GAREN G | Grant, award...etc | 7,693 | 2024-05-16 | ||
| BOHLIN GAREN G | Sale | -28,985 | $32.3 | $936,311 | 2024-05-16 |
| BOHLIN GAREN G | Derivatives Exercise | 28,985 | 2024-05-16 | ||
| Heffernan Michael Thomas | Grant, award...etc | 7,693 | 2024-05-16 | ||
| Melincoff Gwen A | Grant, award...etc | 7,693 | 2024-05-16 | ||
| SANTINI GINO | Grant, award...etc | 7,693 | 2024-05-16 | ||
| Freund John Gordon | Grant, award...etc | 7,693 | 2024-05-16 | ||
| McFarlane Neil F. | Grant, award...etc | 7,693 | 2024-05-16 | ||
| Smith Thomas B | Sale | -995 | $36.76 | $36,580 | 2024-03-04 |
| Dreyer Scott | Sale | -10,000 | $36.38 | $363,754 | 2024-02-28 |
| Tupper Colleen | Sale | -26,321 | $33.7 | $887,018 | 2024-02-14 |
| Tupper Colleen | Grant, award...etc | 71,456 | 2024-02-14 | ||
| Dreyer Scott | Sale | -29,690 | $33.7 | $1,000,553 | 2024-02-14 |
| Dreyer Scott | Grant, award...etc | 67,286 | 2024-02-14 | ||
| Smith Thomas B | Sale | -3,199 | $33.7 | $107,806 | 2024-02-14 |
| Smith Thomas B | Grant, award...etc | 35,423 | 2024-02-14 | ||
| Kuhlmann Shirley R. | Sale | -31,756 | $33.7 | $1,070,177 | 2024-02-14 |
| Kuhlmann Shirley R. | Grant, award...etc | 76,647 | 2024-02-14 | ||
| Ciaffoni Joseph | Sale | -128,867 | $33.7 | $4,342,818 | 2024-02-14 |
| Ciaffoni Joseph | Grant, award...etc | 298,734 | 2024-02-14 | ||
| Dreyer Scott | Sale | -23,560 | $32.28 | $760,519 | 2024-01-18 |
| Ciaffoni Joseph | Sale | -4,357 | $30.38 | $132,377 | 2023-12-22 |
| Ciaffoni Joseph | Derivatives Exercise | 4,357 | 2023-12-22 | ||
| Ciaffoni Joseph | Sale | -68,768 | $30.04 | $2,065,502 | 2023-12-20 |
| Ciaffoni Joseph | Derivatives Exercise | 68,768 | 2023-12-20 | ||
| Kuhlmann Shirley R. | Sale | -25,600 | $25.78 | $660,014 | 2023-11-29 |
| Kuhlmann Shirley R. | Derivatives Exercise | 25,600 | 2023-11-29 | ||
| Kuhlmann Shirley R. | Sale | -17,984 | $21.65 | $389,433 | 2023-06-28 |
| Ciaffoni Joseph | Sale | -62,544 | $22.09 | $1,381,516 | 2023-06-02 |
| Ciaffoni Joseph | Sale | -62,543 | $21.9 | $1,369,836 | 2023-06-01 |
| BOHLIN GAREN G | Grant, award...etc | 9,792 | 2023-05-19 |
The information provided in this report about COLL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Collegium Pharmaceutical, Inc(NASDAQ:COLL) 
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immedia...
Website: http://www.collegiumpharma.com
Founded: 2002
Full Time Employees: 255
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic